C07D 211/76
Attached in position 2 or 6
Official title: attached in position 2 or 6
C07D211/76 (Attached in position 2 or 6) appears on 562 US grants and 458 published applications in this corpus.
Search patents in C07D- Granted patents
- 562
- Published applications
- 458
- Assignees
- 285
- Inventors
- 1,587
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 9 | 0 |
| 1978 | 3 | 0 |
| 1979 | 8 | 0 |
| 1980 | 11 | 0 |
| 1981 | 4 | 0 |
| 1982 | 7 | 0 |
| 1983 | 6 | 0 |
| 1984 | 3 | 0 |
| 1985 | 6 | 0 |
| 1986 | 4 | 0 |
| 1987 | 6 | 0 |
| 1988 | 7 | 0 |
| 1989 | 11 | 0 |
| 1990 | 6 | 0 |
| 1991 | 5 | 0 |
| 1992 | 11 | 0 |
| 1993 | 9 | 0 |
| 1994 | 11 | 0 |
| 1995 | 15 | 0 |
| 1996 | 20 | 0 |
| 1997 | 22 | 0 |
| 1998 | 22 | 0 |
| 1999 | 18 | 0 |
| 2000 | 12 | 0 |
| 2001 | 5 | 1 |
| 2002 | 13 | 18 |
| 2003 | 17 | 22 |
| 2004 | 17 | 27 |
| 2005 | 12 | 19 |
| 2006 | 13 | 25 |
| 2007 | 12 | 14 |
| 2008 | 11 | 14 |
| 2009 | 8 | 21 |
| 2010 | 13 | 26 |
| 2011 | 15 | 18 |
| 2012 | 14 | 15 |
| 2013 | 10 | 18 |
| 2014 | 18 | 15 |
| 2015 | 14 | 16 |
| 2016 | 13 | 19 |
| 2017 | 16 | 17 |
| 2018 | 15 | 19 |
| 2019 | 8 | 8 |
| 2020 | 16 | 20 |
| 2021 | 12 | 26 |
| 2022 | 14 | 18 |
| 2023 | 5 | 18 |
| 2024 | 16 | 17 |
| 2025 | 8 | 15 |
| 2026 | 5 | 12 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Substituted cyclohexyl compounds as NOP inhibitors2 Jun 2026US 12,643,888 B2Dart NeuroScience, LLC
- CRBN ligands and uses thereof3 Feb 2026US 12,540,127 B2Kymera Therapeutics, Inc.
- MDM2 degraders and uses thereof20 Jan 2026US 12,528,785 B2Kymera Therapeutics, Inc.
- Processes for preparing a MDM2 inhibitor13 Jan 2026US 12,526,728 B2Amgen Inc.
- GPX4 inhibitors, pharmaceutical compositions thereof, and their use for treating GPX4-mediated diseases6 Jan 2026US 12,516,016 B2Eubulus Biotherapeutics (Hong Kong) Limited
- Globodera pallida control agent20 Aug 2026US 2026/0240154 A1National Agriculture and Food Research Organization
- Heterocycloalkyl beta-hydroxy alkyl amines for use in the treatment of hyperglycaemia and disorders characterised by hyperglycaemia20 Aug 2026US 2026/0242335 A1Atrogi AB
- Catalyst for sp3-carbon-hydrogen-bond primary amination reaction, and method for preparing primary amine compound13 Aug 2026US 2026/0234096 A1West China Second University Hospital, Sichuan University
- Preparation of an s1p receptor modulator6 Aug 2026US 2026/0226044 A1Oppilan Pharma Ltd.
- Processes for Preparing a MDM2 Inhibitor16 Jul 2026US 2026/0200879 A1Amgen Inc.
Most cited
By later US patents
- Cyclic amine compounds with activity against acetylcholinesterase174US 4,895,841 AEisai Co., Ltd. · 1990
- Fluorescent viability assay using cyclic-substituted unsymmetrical cyanine dyes112US 5,534,416 AMolecular Probes, Inc. · 1996
- Cyclic amine compounds and pharmaceutical use91US 5,100,901 AEisai Co., Ltd. · 1992
- Fibrinogen receptor antagonists for inhibiting aggregation of blood platelets84US 5,281,585 AMerck & Co., Inc. · 1994
- Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds78US 6,759,554 B2Massachusetts Institute of Technology · 2004